Footsie down on US technology forecasts
Gains by drugs stocks were not enough to tempt investors into the wider London market today as a slump in global indices took its toll.
Pharmaceutical giants GlaxoSmithKline and AstraZeneca were the biggest top-flight climbers, up 22p and 35p to 1275p and 2276p respectively, after a court ruling that the patent on one of US counterpart Eli Lilly’s drugs was valid.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





